Bisphenol AF Is a Full Agonist for the Estrogen Receptor ERα but a Highly Specific Antagonist for ERβ | Zendy

Ayami Matsushima | Zendy; Xiaohui Liu | Zendy; Hiroyuki Okada | Zendy; Miki Shimohigashi | Zendy; Yasuyuki Shimohigashi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bisphenol AF Is a Full Agonist for the Estrogen Receptor ERα but a Highly Specific Antagonist for ERβ

Author(s) -

Ayami Matsushima,

Xiaohui Liu,

Hiroyuki Okada,

Miki Shimohigashi,

Yasuyuki Shimohigashi

Publication year - 2010

Publication title -

environmental health perspectives

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.257

H-Index - 282

eISSN - 1552-9924

pISSN - 0091-6765

DOI - 10.1289/ehp.0901819

Subject(s) - estrogen receptor , bisphenol , bisphenol a , agonist , chemistry , receptor , endocrinology , medicine , endocrine disruptor , estrogen receptor alpha , estrogen receptor beta , antagonist , pharmacology , biochemistry , biology , hormone , endocrine system , organic chemistry , cancer , breast cancer , epoxy

Bisphenol AF has been acknowledged to be useful for the production of CF3-containing polymers with improved chemical, thermal, and mechanical properties. Because of the lack of adequate toxicity data, bisphenol AF has been nominated for comprehensive toxicological characterization.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research